A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

Paulus, Walter J., Tschöpe, Carsten·2013·Journal of the American College of Cardiology

Cited by (1,005)

Items 401–500 of 1,005

  1. New Insights in (Inter)Cellular Mechanisms by Heart Failure with Preserved Ejection Fraction
    Carsten Tschöpe, Sophie Van Linthout · 2014 · Current Heart Failure Reports
  2. Cardiac metabolism — A promising therapeutic target for heart failure
    Hannah Noordali, Brodie L. Loudon, Michael Paul Frenneaux, Melanie Madhani · 2017 · Pharmacology & Therapeutics
  3. Combination of Neutrophil‐to‐Lymphocyte and Platelet‐to‐Lymphocyte Ratios as a Novel Predictor of Cardiac Death in Patients With Acute Decompensated Heart Failure With Preserved Left Ventricular Ejection Fraction: A Multicenter Study
    Shunsuke Tamaki, Yoshiyuki Nagai, Ryu Shutta, Daisaku Masuda, Shizuya Yamashita, Masahiro Seo, Takahisa Yamada, Akito Nakagawa, Yoshio Yasumura, Yusuke Nakagawa et al. · 2022 · Journal of the American Heart Association
  4. Gender and cardiovascular disease: are sex-biased microRNA networks a driving force behind heart failure with preserved ejection fraction in women?
    Barend W. Florijn, Roel Bijkerk, Eric P. van der Veer, Anton Jan van Zonneveld · 2017 · Cardiovascular Research
  5. The pathogenic role of coronary microvascular dysfunction in the setting of other cardiac or systemic conditions
    Regina E. Konst, Tomasz Jan Guzik, Juan Carlos Kaski, Angela H.E.M. Maas, Suzette E. Elias‐Smale · 2020 · Cardiovascular Research
  6. Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction
    Ali Ahmad, Michel Corban, Takumi Toya, Frederik Hendrik Verbrugge, Jaskanwal Deep Singh Sara, Lilach O. Lerman, Barry A. Borlaug, Amir Lerman · 2020 · European Journal of Heart Failure
  7. Frailty in Heart Failure
    Izabella Uchmanowicz, Maria Łoboz-Rudnicka, Przemysław Szeląg, Beata Jankowska‐Polańska, Krystyna Łoboz−Grudzień · 2014 · Current Heart Failure Reports
  8. Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart
    Carlo Gabriele Tocchetti, Pietro Ameri, Rudolf A. de Boer, Yuri D’Alessandra, Michele Russo, Daniela Sorriento, Michele Ciccarelli, Bernadett Kiss, Luc Bertrand, Dana K. Dawson et al. · 2020 · Cardiovascular Research
  9. Percutaneous Pericardial Resection
    Barry A. Borlaug, Rickey E. Carter, Vojtěch Melenovský, Christopher V. DeSimone, Prakriti Gaba, Ammar M. Killu, Niyada Naksuk, Lilach O. Lerman, Samuel J. Asirvatham · 2017 · Circulation Heart Failure
  10. Autonomic Neuromodulation Acutely Ameliorates Left Ventricular Strain in Humans
    Nicole T. Tran, Zain Ul Abideen Asad, Khaled Elkholey, Benjamin J. Scherlag, Sunny S. Po, Stavros Stavrakis · 2018 · Journal of Cardiovascular Translational Research
  11. Elevated Inflammatory Plasma Biomarkers in Patients With Fabry Disease: A Critical Link to Heart Failure With Preserved Ejection Fraction
    Haran Yogasundaram, Anish Nikhanj, Brendan Nicholas Putko, Michel Boutin, Shailly Jain‐Ghai, Aneal Khan, Christiane Auray‐Blais, Michael L. West, Gavin Y. Oudit · 2018 · Journal of the American Heart Association
  12. Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart
    Jolanda van der Velden, Folkert Wouter Asselbergs, Jeroen Bakkers, Sandor Batkai, Luc Bertrand, Connie R. Bezzina, Ilze Bot, Bianca J.J.M. Brundel, Lucie Carrier, Steven A. J. Chamuleau et al. · 2022 · Cardiovascular Research
  13. Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits
    Paul J.M. Wijnker, Vasco Sequeira, Diederik W.D. Kuster, Jolanda van der Velden · 2018 · Antioxidants and Redox Signaling
  14. Diagnostic and prognostic value of serum C-reactive protein in heart failure with preserved ejection fraction: a systematic review and meta-analysis
    Ishan Lakhani, Michelle Vangi Wong, Joshua Kai Fung Hung, Mengqi Gong, Khalid Bin Waleed, Yunlong Xia, Sharen Lee, Leonardo Roever, Tong Liu, Gary Tse et al. · 2020 · Heart Failure Reviews
  15. Exercise training reverses cardiac aging phenotypes associated with heart failure with preserved ejection fraction in male mice
    Jason D. Roh, Nicholas E. Houstis, Andy Yu, Bliss J. Chang, Ashish Yeri, Haobo Li, Ryan Hobson, Carolin Lerchenmüller, Ana Vujić, Vinita Chaudhari et al. · 2020 · Aging Cell
  16. Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions
    Anthony E. Peters, Jasper Tromp, Sanjiv Jayendra Shah, Carolyn S.P. Lam, Gregory D. Lewis, Barry A. Borlaug, Kavita Sharma, Ambarish Pandey, Nancy K. Sweitzer, Dalane W. Kitzman et al. · 2022 · Cardiovascular Research
  17. Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review
    Carolyn L. Lekavich, Debra J. Barksdale, Virginia Johnston Neelon, Jiarong R Wu · 2015 · Heart Failure Reviews
  18. Metabolomic Profile in HFpEF vs HFrEF Patients
    Camilla Hage, Lars Löfgren, Filippos Michopoulos, Ralph nilsson, Pia Davidsson, Chanchal Kumar, Mattias Ekström, Maria J. Eriksson, Patrik Lyngå, Bengt Persson et al. · 2020 · Journal of Cardiac Failure
  19. Alteration of circadian machinery in monocytes underlies chronic kidney disease-associated cardiac inflammation and fibrosis
    Yuya Yoshida, Naoya Matsunaga, Takaharu Nakao, Kengo Hamamura, Hideaki Kondo, Tomomi Ide, Hiroyuki Tsutsui, Akito Tsuruta, Masayuki Kurogi, Michio Nakaya et al. · 2021 · Nature Communications
  20. A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction
    Michael Schwarzl, Nazha Hamdani, Sebastian Seiler, Alessio Alogna, Martin Manninger, Svetlana N. Reilly, Birgit Zirngast, Alexander H. Kirsch, Paul Steendijk A, Jochen Verderber et al. · 2015 · American Journal of Physiology-Heart and Circulatory Physiology
  21. One-Year Committed Exercise Training Reverses Abnormal Left Ventricular Myocardial Stiffness in Patients With Stage B Heart Failure With Preserved Ejection Fraction
    Michinari Hieda, Satyam Sarma, Christopher M. Hearon, James P. MacNamara, Katrin A. Dias, Mitchel R. Samels, Dean Palmer, Sheryl A. Livingston, Margot Morris, Benjamin D. Levine · 2021 · Circulation
  22. Monocyte-to-lymphocyte ratio predicts mortality and cardiovascular mortality in the general population
    Yang Hua, Jin-Yu Sun, Yu-Xuan Lou, Wei Sun, Xiangqing Kong · 2023 · International Journal of Cardiology
  23. Incident heart failure and recurrent coronary events following acute myocardial infarction
    Javed Butler, Kendall A. P. Hammonds, Khawaja Muhammad Talha, Ayman Alhamdow, Monica Bennett, Jaccallene Bomar, Jason A. Ettlinger, Monica Martinez Traba, Elisa L. Priest, Niklas Schmedt et al. · 2025 · European Heart Journal
  24. The Association of Chronic Kidney Disease and Microalbuminuria with Heart Failure with Preserved vs. Reduced Ejection Fraction
    Matthew Gregory Nayor, Martin G. Larson, Na Wang, Rajalakshmi Santhanakrishnan, Douglas S. Lee, Connie W. Tsao, Susan C. Cheng, Emelia J. Benjamin, Ramachandran Srini Vasan, Daniel A Levy et al. · 2017 · European Journal of Heart Failure
  25. Growth Differentiation Factor 15 in Adverse Cardiac Remodelling: From Biomarker to Causal Player
    Marian Wesseling, Julius H.C. de Poel, Saskia C.A. de Jager · 2020 · ESC Heart Failure
  26. Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction
    Aish Sinha, Haseeb Rahman, Andrew Webb, Ajay M. Shah, Divaka Perera · 2021 · European Heart Journal
  27. Cyclic GMP and PKG Signaling in Heart Failure
    Genri Numata, Eiki Takimoto · 2022 · Frontiers in Pharmacology
  28. The Implication of the Gut Microbiome in Heart Failure
    Vasile Valeriu Lupu, Anca Adam Răileanu, Cristina Maria Mihai, Ionela Daniela Morariu, Ancuța Lupu, Iuliana Magdalena Stârcea, Otilia Elena Frăsinariu, Adriana Mocanu, Felicia Dragan, Silvia Fotea · 2023 · Cells
  29. Targeting Mitochondrial Calcium Handling and Reactive Oxygen Species in Heart Failure
    Alexander Dietl, Christoph Maack · 2017 · Current Heart Failure Reports
  30. Nrf2 signaling and redox homeostasis in the aging heart: A potential target to prevent cardiovascular diseases?
    Alejandro Silva‐Palacios, Mina Königsberg, Cecilia Zazueta · 2015 · Ageing Research Reviews
  31. Biomarker-Based Phenotyping of Myocardial Fibrosis Identifies Patients with Heart Failure with Preserved Ejection Fraction Resistant to the Beneficial Effects of Spironolactone: Results From the Aldo-DHF Trial
    Susana Ravassa, Tobias Daniel Trippel, Doris Bach, Diana Bachran, Arantxa González, Begoña López, Rolf Wachter, Gerd P Hasenfuss, Christian Delles, Anna F. Dominiczak et al. · 2018 · European Journal of Heart Failure
  32. The molecular mechanisms associated with the physiological responses to inflammation and oxidative stress in cardiovascular diseases
    Saltanat Zhazykbayeva, Steffen Pabel, Andreas Mügge, Samuel Tobias Sossalla, Nazha Hamdani · 2020 · Biophysical Reviews
  33. Reactive Oxygen Species Induced Pathways in Heart Failure Pathogenesis and Potential Therapeutic Strategies
    Aušra Mongirdienė, L Skrodenis, Leila Varoneckaitė, Gerda Mierkytė, Justinas Gerulis · 2022 · Biomedicines
  34. Inflammatory Bowel Disease Is Associated With an Increased Risk of Hospitalization for Heart Failure
    Søren Lund Kristensen, Ole Ahlehoff, Jesper Lindhardsen, Rune Erichsen, Morten Lamberts, Usman Khalid, Ole Haagen Nielsen, Christian Tobias Torp-Pedersen, Gunnar Gislason, Peter Riis Hansen · 2014 · Circulation Heart Failure
  35. The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking
    Arantxa González, Begoña López, Susana Ravassa, Gorka San José, Javier Dı́ez · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  36. Galectin-3 in Heart Failure With Preserved Ejection Fraction
    Omar F. AbouEzzeddine, Phillip Haines, Susanna R. Stevens, Jose N. Nativi-Nicolau, Gary Michael Felker, Barry A. Borlaug, Horng H. Chen, Russell P. Tracy, Eugene Braunwald M. D, Margaret M. Redfield · 2015 · JACC Heart Failure
  37. Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction
    Senthil Selvaraj, Brian Lee Claggett, Sanjiv Jayendra Shah, Inder S. Anand, Jean Lucien Rouleau, Eileen O’Meara, Akshay Suvas Desai, Eldrin Foster Lewis, Bertram Pitt, Nancy K. Sweitzer et al. · 2018 · Circulation Heart Failure
  38. Sarcopenia in Cirrhosis: Looking Beyond the Skeletal Muscle Loss to See the Systemic Disease
    Rahima A. Bhanji, Aldo J. Montaño‐Loza, Kymberly D. S. Watt · 2019 · Hepatology
  39. Mitochondrial protection by simvastatin against angiotensin II‐mediated heart failure
    Chong‐Chao Hsieh, Chia‐Yang Li, Chih‐Hsin Hsu, Hsiu‐Lin Chen, Yung‐Hsiang Chen, Yu‐Peng Liu, Yuru Liu, Hsuan‐Fu Kuo, Po‐Len Liu · 2019 · British Journal of Pharmacology
  40. Heart Failure With Preserved Ejection Fraction: A Comprehensive Review and Update of Diagnosis, Pathophysiology, Treatment, and Perioperative Implications
    Paul S. Pagel, Justin N. Tawil, Brent T. Boettcher, David A. Izquierdo, Timothy J. Lazicki, George J. Crystal, Julie K. Freed · 2020 · Journal of Cardiothoracic and Vascular Anesthesia
  41. Inflammation and Cardiovascular Diseases in the Elderly: The Role of Epicardial Adipose Tissue
    Maddalena Conte, Laura Petraglia, Paolo Poggio, Vincenza Valerio, Serena Cabaro, Pasquale Campana, Giuseppe Comentale, Emilio Attena, Vincenzo Russo, Emanuele Pilato et al. · 2022 · Frontiers in Medicine
  42. Heart failure with preserved ejection fraction (HFpEF) in type 2 diabetes mellitus: from pathophysiology to therapeutics
    Miyesaier Abudureyimu, Xuanming Luo, Xiang Wang, James R. Sowers, Wenshuo Wang, Junbo Ge, Jun Tao Ren, Yingmei Zhang · 2022 · Journal of Molecular Cell Biology
  43. Insulin-Like Growth Factor–Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction
    Parul U. Gandhi, Hanna Kim Gaggin, Margaret M. Redfield, Horng H. Chen, Susanna R. Stevens, Kevin Joseph Anstrom, Marc J. Semigran, Peter Xiaoping Liu, James L. Januzzi · 2016 · JACC Heart Failure
  44. Microvascular endothelial dysfunction in heart failure with preserved ejection fraction
    Lam, Carolyn S P, Lund, Lars H · 2016 · Heart
  45. Spermidine activates RIP1 deubiquitination to inhibit TNF-α-induced NF-κB/p65 signaling pathway in osteoarthritis
    Zhong Chen, C. X. Lin, Bin Song, Chang-Chuan Li, Junxiong Qiu, Shi-Xun Li, Sipeng Lin, Wenqiang Luo, Yuan Fu, Guibin Fang et al. · 2020 · Cell Death and Disease
  46. How to Manage Heart Failure With Preserved Ejection Fraction
    Akshay Suvas Desai, Carolyn S.P. Lam, John J.V. McMurray, Margaret M. Redfield · 2023 · JACC Heart Failure
  47. Soluble ST2 in Heart Failure With Preserved Ejection Fraction
    Omar F. AbouEzzeddine, Paul M. McKie, Shannon M. Dunlay, Susanna R. Stevens, Gary Michael Felker, Barry A. Borlaug, Horng H. Chen, Russell P. Tracy, Eugene Braunwald M. D, Margaret M. Redfield · 2017 · Journal of the American Heart Association
  48. Association of Low-Grade Albuminuria With Adverse Cardiac Mechanics
    Daniel H. Katz, Senthil Selvaraj, Frank G. Aguilar, Eva E. Martinez, Lauren Beussink‐Nelson, Kwang‐Youn A. Kim, Jie Peng, Jin Sha, Marguerite R. Irvin, John H. Eckfeldt et al. · 2013 · Circulation
  49. Heart failure with preserved ejection fraction: current management and future strategies
    Carsten Tschöpe, Christoph M. Birner, Michael Böhm, Oliver Bruder, Stefan Frantz, Andreas Luchner, Lars Siegfried Maier, Stefan Störk, Behrouz Kherad, Ulrich Laufs · 2017 · Clinical Research in Cardiology
  50. What have we Learned About Heart Failure with Mid-Range Ejection Fraction One Year After its Introduction?
    Jan F. Nauta, Yoran M. Hummel, Joost P. van Melle, Peter van der Meer, Carolyn S.P. Lam, Piotr P. Ponikowski, Adriaan A. Voors · 2017 · European Journal of Heart Failure
  51. Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications
    Daniela Maria Tănase, Smaranda Radu, Sinziana Al Shurbaji, Genoveva Livia Baroi, Claudia Florida Costea, Mihaela Dana Turliuc, Anca Ouatu, Mariana Floria · 2019 · International Journal of Molecular Sciences
  52. Unfolding Discoveries in Heart Failure
    Walter J. Paulus · 2020 · New England Journal of Medicine
  53. Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction
    Ambarish Pandey, Hassan Khan, Anne B. Newman, Edward G. Lakatta, Daniel E. Forman, Javed Butler, Jarett D. Berry · 2016 · Hypertension
  54. Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease
    Barry A. Borlaug, Masaru Obokata · 2017 · European Heart Journal
  55. Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction
    Grazia Esposito, Donato Cappetta, Rosa Russo, Alessia Rivellino, Loreta Pia Ciuffreda, Fiorentina Roviezzo, Elena Piegari, Liberato Berrino, Francesco Rossi, Antonella De Angelis et al. · 2016 · British Journal of Pharmacology
  56. Biomarkers of Inflammation in Left Ventricular Diastolic Dysfunction
    Mihaela Mocan, Larisa Diana Mocan Hognogi, Florin Petru Anton, Roxana Mihaela Chiorescu, Cerasela Mihaela Goidescu, Mirela Anca Stoia, Anca Daniela Fărcaș · 2019 · Disease Markers
  57. Empagliflozin restores chronic kidney disease–induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction
    Rio P. Juni, Rushd Al‐Shama, Diederik W.D. Kuster, Jolanda van der Velden, Henrike M. Hamer, Marc G. Vervloet, Etto C. Eringa, Pieter Koolwijk, Victor W.M. van Hinsbergh · 2020 · Kidney International
  58. Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
    Arantxa González, Mark Richards, Rudolf A. de Boer, Thomas Thum, Henrike Arfsten, Martin Hülsmann, Inês Falcão‐Pires, Javier Dı́ez, Roger Foo, Mark Y. Chan et al. · 2022 · European Journal of Heart Failure
  59. Epidemiology, Pathophysiology, Diagnosis, and Therapy of Heart Failure With Preserved Ejection Fraction in Japan
    Masaru Obokata, Hidemi Sorimachi, Tomonari Harada, Kazuki Kagami, Yuki Saito, Hideki Ishii · 2023 · Journal of Cardiac Failure
  60. Hypertension and Heart Failure: From Pathophysiology to Treatment
    Giovanna Gallo, Carmine Savoia · 2024 · International Journal of Molecular Sciences
  61. C-Reactive Protein Predicts Mortality in Patients Referred for Coronary Angiography and Symptoms of Heart Failure With Preserved Ejection Fraction
    Lorenz Koller, Marcus Edi Kleber, Georg Goliasch, Patrick Sulzgruber, Hubert Scharnagl, Günther Silbernagel, Tanja B. Grammer, G. Delgado, Andreas Tomaschitz, Stefan Pilz et al. · 2014 · European Journal of Heart Failure
  62. Growth Differentiation Factor-15 Is a Useful Prognostic Marker in Patients With Heart Failure With Preserved Ejection Fraction
    Yasuhiro Izumiya, Shinsuke Hanatani, Yuichi Kimura, Seiji Takashio, Eiichiro Yamamoto, Hiroaki Kusaka, Takanori Tokitsu, Taku Rokutanda, Satoshi Araki, Kenichi Tsujita et al. · 2013 · Canadian Journal of Cardiology
  63. Sarcopenic Obesity and the Pathogenesis of Exercise Intolerance in Heart Failure with Preserved Ejection Fraction
    Bharathi Upadhya, Mark J. Haykowsky, Joel Eggebeen, Dalane W. Kitzman · 2015 · Current Heart Failure Reports
  64. The challenge of frailty and sarcopenia in heart failure with preserved ejection fraction
    Yoshiharu Kinugasa, Kazuhiro Yamamoto · 2016 · Heart
  65. Atrial Fibrillation–Mediated Cardiomyopathy
    Dingxin Qin, MOUSSA C. MANSOUR, Jeremy Neil Ruskin, Edwin Kevin Heist · 2019 · Circulation Arrhythmia and Electrophysiology
  66. Heart failure with preserved ejection fraction based on aging and comorbidities
    Ying H. Lin, Shihui Fu, Yao Yao, Yulong Li, Yali Zhao, Leiming Luo · 2021 · Journal of Translational Medicine
  67. Natriuretic peptide pathways in heart failure: further therapeutic possibilities
    S. Jeson Sangaralingham, Michaela Kühn, Valentina Cannone, Horng H. Chen, John C. Jr Burnett · 2022 · Cardiovascular Research
  68. p53-Induced inflammation exacerbates cardiac dysfunction during pressure overload
    Yohko Yoshida, Ippei Shimizu, Goro Katsuumi, Shuang Jiao, Masayoshi Suda, Yuka Hayashi, Tohru Minamino · 2015 · Journal of Molecular and Cellular Cardiology
  69. Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice
    Brian Bostick, Javad Habibi, Vincent Gerard DeMarco, Guanghong Jia, Timothy L. Domeier, Michelle D. Lambert, Annayya Rao Aroor, Ravi Nistala, Shawn B. Bender, Mona Garro et al. · 2015 · American Journal of Physiology-Heart and Circulatory Physiology
  70. Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome
    Chris Van Dijk, Nynke R. Oosterhuis, Yan Juan Xu, Maarten M. Brandt, Walter J. Paulus, Loek van Heerebeek, Dirk Jan Duncker, Marianne Christina Verhaar, Dulce Fontoura, André Pedro Lourenço et al. · 2016 · Circulation Heart Failure
  71. Load-Independent Systolic and Diastolic Right Ventricular Function in Heart Failure With Preserved Ejection Fraction as Assessed by Resting and Handgrip Exercise Pressure–Volume Loops
    Karl‐Philipp Rommel, Maximilian von Roeder, Christian Oberueck, Konrad Latuscynski, Christian Besler, Stephan Blazek, Thomas Stiermaier, Karl Fengler, Volker Adams, Marcus Sandri et al. · 2018 · Circulation Heart Failure
  72. Reduced lymphatic reserve in heart failure with preserved ejection fraction
    Rossitto, Giacomo, Mary, Sheon, McAllister, Christine, Neves, Karla Bianca, Haddow, Laura, Rocchiccioli, John Paul, Lang, Ninian Nicholas, Murphy, Clare Louise, Touyz, Rhian Merry, Petrie, Mark Colquhoun et al. · 2020 · Journal of the American College of Cardiology
  73. Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF
    Gianluigi Savarese, Nicola Orsini, Camilla Hage, Ola Vedin, Francesco Cosentino, Giuseppe M.C. Rosano, Ulf Dahlström, Lars H. Lund · 2018 · JACC Heart Failure
  74. Heart Failure With Preserved Ejection Fraction in Diabetes: Mechanisms and Management
    Patrick Meagher, Mohamed Adam, Robert Civitarese, Antoinette Bugyei‐Twum, Kim Alexander Connelly · 2018 · Canadian Journal of Cardiology
  75. Treatment of Angina: Where Are We?
    Cristina Balla, Rita Pavasini, Roberto Ferrari · 2018 · Cardiology
  76. Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: A systematic review and meta-analysis
    Karn Wijarnpreecha, Susan M. Lou, Panadeekarn Panjawatanan, Wisit Cheungpasitporn, Surakit Pungpapong, Frank Lukens, Patompong Ungprasert · 2018 · Digestive and Liver Disease
  77. Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk‐related rat model of heart failure with preserved ejection fraction
    Daniela Miranda‐Silva, Rob C. I. Wüst, Glória Conceição, Patrícia Gonçalves‐Rodrigues, Nádia Gonçalves, Alexandre Gonçalves, Diederik W.D. Kuster, Adelino Ferreira Leite-Moreira, Jolanda van der Velden, Jorge Beleza et al. · 2019 · Acta Physiologica
  78. Mechanics of right ventricular dysfunction in pulmonary arterial hypertension and heart failure with preserved ejection fraction
    Roberto J. Bernardo, François Haddad, Étienne J. Couture, Georg Hansmann, Vinicio de Jesús Pérez, André Yvan Denault, Frances S. de Man, Myriam Amsallem · 2020 · Cardiovascular Diagnosis and Therapy
  79. The Physiology and Pathophysiology of T-Tubules in the Heart
    Ingunn E. Setterberg, Christopher Le, Michael Frisk, Harmonie Perdreau‐Dahl, Jia Li, William Edward Louch · 2021 · Frontiers in Physiology
  80. HMGB1‐Promoted Neutrophil Extracellular Traps Contribute to Cardiac Diastolic Dysfunction in Mice
    Xin‐Lin Zhang, Ting‐Yu Wang, Zheng Chen, Hong‐Wei Wang, Yong Yin, Lian Wang, Yong Wang, Biao Xu, Wei Xu · 2022 · Journal of the American Heart Association
  81. Cigarette Smoking, Cessation, and Risk of Heart Failure With Preserved and Reduced Ejection Fraction
    Ning Ding, Amil M. Shah, Michael Joseph Blaha, Patricia P. Chang, Wayne D. Rosamond, Kunihiro Matsushita · 2022 · Journal of the American College of Cardiology
  82. Left ventricular diastolic dysfunction and myocardial stiffness in diabetic mice is attenuated by inhibition of dipeptidyl peptidase 4
    Nazha Hamdani, Anne-Sophie Hervent, Leni Vandekerckhove, Veerle Matheeussen, Marc J. Demolder, Lesley Baerts, Ingrid De Meester, Wolfgang Albrecht Linke, Walter J. Paulus, Gilles W. De Keulenaer · 2014 · Cardiovascular Research
  83. Murine Models of Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction
    Stephen James Horgan, C. Watson, Nadezhda Glezeva, John Andrew Baugh · 2014 · Journal of Cardiac Failure
  84. Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction
    M Boulogne, Malha Sadoune, Jean‐Marie Launay, Mathilde Baudet, Alain Cohen Solal, Damien Logeart · 2016 · International Journal of Cardiology
  85. Chronic Inhibition of PDE5 Limits Pro-Inflammatory Monocyte-Macrophage Polarization in Streptozotocin-Induced Diabetic Mice
    Mary Anna Venneri, Elisa Giannetta, Giuseppe Panio, Rita De Gaetano, Daniele Gianfrilli, Riccardo Pofi, Silvia Masciarelli, Francesco Fazi, Manuela Pellegrini, Andrea Lenzi et al. · 2015 · PLoS ONE
  86. Sex Differences in the Coronary System
    Viviany R. Taqueti · 2018 · Advances in experimental medicine and biology
  87. Epidemiology and Clinical Features of Heart Failure with Preserved Ejection Fraction
    KANAKO TERAMOTO, Tiew‐Hwa Katherine Teng, Chanchal Chandramouli, Jasper Tromp, Yasuhiko Sakata, Carolyn S.P. Lam · 2022 · Cardiac failure review
  88. Sex differences in heart failure with preserved ejection fraction: From traditional risk factors to sex-specific risk factors
    Gurleen Kaur, Emily S. Lau · 2022 · Women s Health
  89. Extracellular matrix remodelling in obesity and metabolic disorders
    Vishal Musale, David H. Wasserman, Li Kang · 2023 · Life Metabolism
  90. Clinical Characteristics and Social Frailty of Super-Elderly Patients With Heart Failure ― The Kitakawachi Clinical Background and Outcome of Heart Failure Registry ―
    Kensuke Takabayashi, Akihiro Ikuta, Yoshinori Okazaki, M. Ogami, Kotaro Iwatsu, Koichi Matsumura, Tsutomu Ikeda, Tahei Ichinohe, Yuko Morikami, Takashi Yamamoto et al. · 2016 · Circulation Journal
  91. Increased passive stiffness promotes diastolic dysfunction despite improved Ca2+ handling during left ventricular concentric hypertrophy
    Åsmund Treu Røe, Jan Magnus Aronsen, Kristine Skårdal, Nazha Hamdani, Wolfgang Albrecht Linke, Havard Emil Danielsen, Ole Mathias Sejersted, Ivar Sjaastad, William Edward Louch · 2017 · Cardiovascular Research
  92. Low‐level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction
    Liping Zhou, Adrian Filiberti, Mary Beth Humphrey, Christian D. Fleming, Benjamin J. Scherlag, Sunny S. Po, Stavros Stavrakis · 2018 · Experimental Physiology
  93. Spironolactone for Heart Failure with Preserved Ejection Fraction
    Georgios K. Efthimiadis, Thomas Zegkos, Haralambos Karvounis · 2014 · New England Journal of Medicine
  94. Heart Failure with Preserved Ejection Fraction
    James D. Gladden, Antoine H. Chaanine, Margaret M. Redfield · 2018 · Annual Review of Medicine
  95. Estrogen Contributions to Microvascular Dysfunction Evolving to Heart Failure With Preserved Ejection Fraction
    Ariane A. Sickinghe, Suzanne J.A. Korporaal, Hester M. den Ruijter, Elise L. Kessler · 2019 · Frontiers in Endocrinology
  96. Sodium Glucose Co-Transporter 2 Inhibitors Ameliorate Endothelium Barrier Dysfunction Induced by Cyclic Stretch through Inhibition of Reactive Oxygen Species
    Xiaoling Li, Gregor Römer, Raphaela P. Kerindongo, Jeroen Hermanides, Martin Albrecht, Markus Werner Hollmann, Coert Jozef Zuurbier, Benedikt Preckel, Nina Claudia Weber · 2021 · International Journal of Molecular Sciences
  97. Cardiac Hypertrophy: From Pathophysiological Mechanisms to Heart Failure Development
    Alfredo Caturano, Erica Vetrano, Raffaele Galiero, Teresa Salvatore, Giovanni Docimo, Raffaella Epifani, Maria Alfano, Celestino Sardu, Raffaele Marfella, Luca Rinaldi et al. · 2022 · Reviews in Cardiovascular Medicine
  98. Myocardial injury, troponin release, and cardiomyocyte death in brief ischemia, failure, and ventricular remodeling
    John M. Canty · 2022 · American Journal of Physiology-Heart and Circulatory Physiology
  99. Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: A novel potential therapeutic target?
    Manyi Ren, Xiuzhen Li, Li Hao, Jingquan Zhong · 2015 · Annals of Medicine
  100. Skeletal Muscle Alterations Are Exacerbated in Heart Failure With Reduced Compared With Preserved Ejection Fraction
    Martin Seiler, Thomas Scott Bowen, Natale P. L. Rolim, Maja‐Theresa Dieterlen, Sarah Werner, Tomoya Hoshi, Tina Fischer, Norman Mangner, Axel Hans-Peter Linke, Gerhard C Schuler et al. · 2016 · Circulation Heart Failure